FDA seeks more patient input

05/16/2013 | MedCityNews.com

The FDA is trying to engage more patients at earlier stages of the agency's decision-making processes, asking for patient input not only on drug approvals but also on clinical trial design, unmet medical needs, and the utility of new drugs and devices. "When it comes down to final decision, we want input on what risk patients are willing to tolerate to get the benefits," said James Valentine, program manager at the FDA Office of Health and Constituent Affairs.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA